Adam R. Wolfe Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Assistant Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

15 h-index 81 pubs 1,041 cited

Research Areas

Links

ORCID

OverviewAI-generated summary

Adam R. Wolfe is an Assistant Professor at the University of Arkansas for Medical Sciences. His research focuses on understanding the mechanisms underlying microbial infections and disease. He has published work investigating the role of specific bacteria, such as Staphylococcus aureus, in causing infections and the development of antibiotic resistance. His work also explores host-pathogen interactions and potential therapeutic interventions.

Metrics

h-index: 15
Publications: 81
Citations: 1,041

Selected Publications

Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025)

DOI OpenAlex
SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models (2025)

DOI OpenAlex
Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience (2025)

2 citations DOI OpenAlex
Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025)

DOI OpenAlex
Spatially Fractionated Radiotherapy GRID for Bulky Tumor: A Large Single Institution Experience (2024)

1 citation DOI OpenAlex
Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)

DOI OpenAlex
RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers (2024)

5 citations DOI OpenAlex
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions (2024)

12 citations DOI OpenAlex
Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer (2024)

DOI OpenAlex
Ras-Raf-Mir-296-3p Signaling Axis Increases Rad18 Expression to Augment Radioresistance in Pancreatic and Thyroid Cancers (2023)

1 citation DOI OpenAlex
Outcomes of Moderately Dose Escalated Hypofractionated Chemoradiation for Pancreatic Cancer (2023)

DOI OpenAlex
Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy (2023)

DOI OpenAlex
Diagnostic discovery (2023)

1 citation DOI OpenAlex
Diagnostic testing (2023)

DOI OpenAlex
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)

DOI OpenAlex